XML 100 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation - (Tables)
12 Months Ended
Jan. 01, 2022
Share-based Payment Arrangement [Abstract]  
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
The number and weighted-average exercise price of options issued and outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted-average exercise prices):
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Year Ended
December 28,
2019
SharesAverage
Exercise
Price
SharesAverage
Exercise
Price
SharesAverage
Exercise
Price
Options outstanding, beginning of period3,448 $77.44 5,212 $54.23 5,676 $43.61 
Granted85 250.15 400 187.83 545 140.56 
Canceled/Forfeited(171)149.11 (219)126.98 (158)83.14 
Exercised(391)53.55 (1,945)32.41 (851)33.32 
Options outstanding, end of period2,971 $81.38 3,448 $77.44 5,212 $54.23 
Options exercisable, end of period2,175 $57.09 2,026 $47.31 3,311 $33.80 
Number and Weighted Average Exercise Price of Outstanding and Exercisable Options
The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges (in thousands, except range of exercise prices and remaining contractual life) were as follows:
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Options OutstandingOptions
Exercisable
Options OutstandingOptions
Exercisable
Range of Exercise PricesNumber of
Options
Average
Remaining
Contractual
Life
Number of
Options
Number of
Options
Average
Remaining
Contractual
Life
Number of
Options
$15.00 to $50.00
1,426 3.331,426 1,696 4.141,518 
$50.01 to $80.00
31 4.7529 42 5.8026 
$80.01 to $120.00
805 5.81544 910 6.83408 
$120.01 to $160.00
356 7.36124 476 8.4174 
$160.01 to $200.00
226 8.1841 255 9.17— 
$200.01 to $230.00
29 8.5437 9.50— 
$230.01 to $280.00
98 8.9732 9.53— 
     Total2,971 5.112,175 3,448 5.902,026 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted average grant date fair value amounts):
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Year Ended
December 28,
2019
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
RSUs outstanding, beginning of period2,862 $99.66 2,797 $96.85 2,707 $95.54 
Granted112 257.43 98 193.77 100 133.57 
Canceled/Forfeited(23)204.33 (6)165.03 (3)133.50 
Vested(35)163.71 (27)134.78 (7)99.05 
RSUs outstanding, end of period2,916 $104.13 2,862 $99.66 2,797 $96.85 
Schedule of Nonvested Performance-based Units Activity
The number of PSUs outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted average grant date fair value amounts):
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Year Ended
December 28,
2019
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
PSUs outstanding, beginning of period444 $120.28 412 $102.22 313 $88.34 
Granted148 
(1)
250.73 97 179.42 128 133.50 
Canceled/Forfeited(17)166.84 (7)122.13 — — 
Vested(272)86.95 (58)90.69 (29)90.69 
PSUs outstanding, end of period303 $168.68 444 $120.28 412 $102.22 
(1) On February 22, 2021, the Audit Committee approved the weighted payout percentage for the 2018 PSU awards (three-year performance period), which were based upon the Company’s actual fiscal year 2020 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target.
Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Risk-free interest rate
0.3% to 0.9%
0.2% to 1.7%
1.4% to 2.6%
Expected term
5.1 years to 5.6 years
5.1 years to 5.1 years
5.1 years to 5.2 years
Estimated volatility
30.9% to 34.7%
26.9% to 35.5%
28.2% to 30.0%
Expected dividends0%0%0%
Weighted-average fair value of options granted$75.72 per share$51.10 per share$42.29 per share
Total Share-Based Compensation Expense Included in Consolidated Statements of Comprehensive Income
The following table presents the total stock-based compensation expense that is included in each functional line item of the consolidated statements of operations (in thousands):
Year Ended
January 1,
2022
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Cost of goods sold$839 $714 $445 
Selling, general and administrative31,315 31,462 30,450 
Research and development12,470 10,049 8,340 
Total
$44,624 $42,225 $39,235